Profile data is unavailable for this security.
About the company
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
- Revenue in JPY (TTM)2.45tn
- Net income in JPY34.84bn
- Incorporated1946
- Employees12.92k
- LocationSuzuken Co Ltd8, Higashi Kataha-machi, Higashi-kuNAGOYA-SHI 461-8701JapanJPN
- Phone+81 529612331
- Fax+81 529715837
- Websitehttps://www.suzuken.co.jp
Mergers & acquisitions
| Acquired company | 9987:TYO since announced | Transaction value |
|---|---|---|
| medimo Inc | -4.43% | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 06 Jun 2025 | 6.37m | 8.83% |
| Silchester International Investors LLPas of 10 Jul 2025 | 5.14m | 7.13% |
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2025 | 4.03m | 5.58% |
| Columbia Management Investment Advisers LLCas of 31 Jan 2026 | 2.21m | 3.07% |
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 2.17m | 3.01% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.09m | 2.90% |
| Orbis Portfolio Management (Europe) LLPas of 30 Jun 2025 | 1.58m | 2.19% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2025 | 1.37m | 1.90% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 1.24m | 1.72% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 1.10m | 1.52% |
